Tools for optimizing risk assessment in hematopoietic cell transplant - What can we get away with?
Hum Immunol
; 83(10): 704-711, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35120770
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Hematologic Neoplasms
/
Graft vs Host Disease
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Hum Immunol
Year:
2022
Document type:
Article
Country of publication: